KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Raw Materials (2021 - 2023)

Historic Raw Materials for Ginkgo Bioworks Holdings (DNA) over the last 3 years, with Q2 2023 value amounting to $905000.0.

  • Ginkgo Bioworks Holdings' Raw Materials rose 486.67% to $905000.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $905000.0, marking a year-over-year increase of 486.67%. This contributed to the annual value of $1.6 million for FY2022, which is 238437.5% up from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Raw Materials stood at $905000.0 for Q2 2023, which was up 486.67% from $2.3 million recorded in Q1 2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Raw Materials registered a high of $2.3 million during Q1 2023, and its lowest value of $64000.0 during Q4 2021.
  • For the 3-year period, Ginkgo Bioworks Holdings' Raw Materials averaged around $1.1 million, with its median value being $884000.0 (2022).
  • In the last 5 years, Ginkgo Bioworks Holdings' Raw Materials surged by 238437.5% in 2022 and then skyrocketed by 486.67% in 2023.
  • Quarter analysis of 3 years shows Ginkgo Bioworks Holdings' Raw Materials stood at $64000.0 in 2021, then soared by 2384.38% to $1.6 million in 2022, then crashed by 43.08% to $905000.0 in 2023.
  • Its last three reported values are $905000.0 in Q2 2023, $2.3 million for Q1 2023, and $1.6 million during Q4 2022.